Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the pharmacokinetics of an oral omadacycline dosing regimen in the treatment of adults with CABP.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Paratek Pharmaceuticals Inc
NCT06966310 · Community-acquired Pneumonia
NCT06294600 · Community-acquired Pneumonia
NCT07278700 · Acute Respiratory Infections, Febrile Illnesses, and more
NCT07164131 · Community-acquired Pneumonia
NCT06295120 · Community-acquired Pneumonia
Site 105
Birmingham, Alabama
Site 102
San Diego, California
Site 104
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions